Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Hyperplasia 1

Interventions

Cisplatin 3193 Cyclophosphamide 3187 Carboplatin 2968 Radiotherapy 2784 Paclitaxel 2716 Gemcitabine 2569 pembrolizumab 2378 Bevacizumab 2206 Docetaxel 2196 Fluorouracil 1848 Capecitabine 1828 Oxaliplatin 1738 Dexamethasone 1604 Nivolumab 1580 Doxorubicin 1501 Rituximab 1487 Magnetic Resonance Spectroscopy 1382 Etoposide 1345 Irinotecan 1245 Leucovorin 1222 Drug Therapy 1202 Cytarabine 1130 Pemetrexed 1074 fludarabine 1056 Specimen Handling 1009 Vincristine 964 Cetuximab 943 Prednisone 940 Trastuzumab 940 Lenalidomide 937

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

5-alpha Reductase Inhibitors × Clear all

NCT01767363 2016-11-09

WEUSKOP5723: Prostate Cancer Study

GlaxoSmithKline

Prostatic Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡